3,287
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Genome-wide Expression Profiling of Human Lymphoblastoid Cell Lines Identifies CHL1 as a Putative SSRI Antidepressant Response Biomarker

, , , , &
Pages 171-184 | Published online: 18 Feb 2011

Bibliography

  • Souery D , OswaldP, MassatI et al.: Clinical factors associated with treatment resistance in major depressive disorder: results from a European multicenter study.J. Clin. Psychiatry68(7) , 1062–1070 (2007).
  • Kirchheiner J , NickchenK, BauerM et al.: Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response.Mol. Psychiatry9(5) , 442–473 (2004).
  • Gelenberg AJ : A review of the current guidelines for depression treatment.J. Clin. Psychiatry71(7) , e15 (2010).
  • Maas DW , WestendorpRG, WillemsJM, de Craen AJ, van der Mast RC: TNF-(a) Antagonist infliximab in the treatment of depression in older adults: results of a prematurely ended, randomized, placebo-controlled trial. J. Clin. Psychopharm.30(3) , 343–345 (2010).
  • Serretti A , CalatiR, MassatI et al.: Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes are not associated with response and remission in a sample of depressive patients.Int. Clin. Psychopharmacol.24(5) , 250–256 (2009).
  • Thakur M , GrossmanI, McCroryDC et al.: Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitors.Genet. Med.9(12) , 826–835 (2007).
  • Rausch JL : Initial conditions of psychotropic drug response: studies of serotonin transporter long promoter region (5-HTTLPR), serotonin transporter efficiency, cytokine and kinase gene expression relevant to depression and antidepressant outcome.Prog. Neuropsychopharmacol. Biol. Psychiatry29(6) , 1046–1061 (2005).
  • Zanardi R , BenedettiF, Di Bella D, Catalano M, Smeraldi E: Efficacy of paroxetine in depression is influenced by a functional polymorphism within the promoter of the serotonin transporter gene. J. Clin. Psychopharmacol.20(1) , 105–107 (2000).
  • Illi A , Setälä-SoikkeliE, KampmanO et al.: Catechol-O-methyltransferase val108/158met genotype, major depressive disorder and response to selective serotonin reuptake inhibitors in major depressive disorder.Psychiatry Res.176(1) , 85–87 (2010).
  • Taylor MJ , SenS, BhagwagarZ: Antidepressant response and the serotonin transporter gene-linked polymorphic region.Biol Psychiatry68(6) , 536–543 (2010)
  • Lucae S , IsingM, HorstmannS et al.: HTR2A gene variation is involved in antidepressant treatment response.Eur. Neuropsychopharmacol.20(1) , 65–68 (2010).
  • Binder EB , OwensMJ, LiuW et al.: Association of polymorphisms in genes regulating the corticotropin-releasing factor system with antidepressant treatment response.Arch. Gen. Psychiatry.67(4) , 369–379 (2010).
  • McHugh PC , JoycePR, DengX, KennedyMA: A polymorphism of the GTP-cyclohydrolase I feedback regulator gene alters transcriptional activity and may affect response to SSRI antidepressants.Pharmacogenomics J. (2010) (Epub ahead of print).
  • Talbot JN , JutkiewiczEM, GravesSM et al.: RGS inhibition at G(α)i2 selectively potentiates 5-HT1A-mediated antidepressant effects.Proc. Natl Acad. Sci USA107(24) , 11086–11091 (2010).
  • Ising M , LucaeS, BinderEB et al.: A genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depression.Arch. Gen. Psychiatry66(9) , 966–975 (2009).
  • Garriock HA , KraftJB, ShynSI et al.: A genomewide association study of citalopram response in major depressive disorder.Biol. Psychiatry67(2) , 133–138 (2010).
  • Uher R , PerroudN, NgMY et al.: Genome-wide pharmacogenetics of antidepressant response in the GENDEP project.Am. J. Psychiatry167(5) , 555–564 (2010).
  • Goldstein DB : Common genetic variation and human traits.N. Engl. J. Med.360(17) , 1696–1698 (2009).
  • Zhang W , DolanME. Use of cell lines in the investigation of pharmacogenetic loci. Curr. Pharm. Des.15(32) , 3782–3795 (2009).
  • Coulombe-Huntington J , LamKC, DiasC, MajewskiJ: Fine-scale variation and genetic determinants of alternative splicing across individuals.PLoS Genet.5(12) , e1000766 (2009).
  • Bleibel WK , DuanS, HuangRS et al.: Identification of genomic regions contributing to etoposide-induced cytotoxicity.Hum. Genet.125(2) , 173–180 (2009).
  • Dolan ME , NewboldKG, NagasubramanianR et al.: Heritability and linkage analysis of sensitivity to cisplatin-induced cytotoxicity.Cancer Res.64(12) , 4353–4356 (2004).
  • Hartford CM , DuanS, DelaneySM et al.: Population-specific genetic variants important in susceptibility to cytarabine arabinoside cytotoxicity.Blood113(10) , 2145–2153 (2009).
  • Huang RS , DuanS, BleibelWK et al.: A genome-wide approach to identify genetic variants that contribute to etoposide-induced cytotoxicity.Proc. Natl Acad. Sci. USA104(23) , 9758–9763 (2007).
  • Pinto N , LudemanSM, DolanME: Drug focus: pharmacogenetic studies related to cyclophosphamide-based therapy.Pharmacogenomics10(12) , 1897–1903 (2009).
  • Li L , FridleyB, KalariK et al.: Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression.Cancer Res.68(17) , 7050–7058 (2008).
  • Fry RC , SvenssonJP, ValiathanC et al.: Genomic predictors of interindividual differences in response to DNA damaging agents.Genes Dev.22(19) , 2621–2626 (2008).
  • Abdul M , LogothetisCJ, HooseinNM: Growth-inhibitory effects of serotonin uptake inhibitors on human prostate carcinoma cell lines.J. Urol.154(1) , 247–250 (1995).
  • Volpe DA , EllisonCD, ParchmentRE, GrieshaberCK, FaustinoPJ: Effects of amitriptyline and fluoxetine upon the in vitro proliferation of tumor cell lines.J. Exp. Ther. Oncol.3(4) , 169–184 (2003).
  • Rosetti M , FrasnelliM, TeseiA, ZoliW, ContiM: Cytotoxicity of different selective serotonin reuptake inhibitors (SSRIs) against cancer cells.J. Exp Ther. Oncol.6(1) , 23–29 (2006).
  • Serafeim A , HolderMJ, GraftonG et al.: Selective serotonin reuptake inhibitors directly signal for apoptosis in biopsy-like Burkitt lymphoma cells.Blood101(8) , 3212–3219 (2003).
  • Morag A , KirchheinerJ, RehaviM, GurwitzD: Human lymphoblastoid cell line panels: novel tools for assessing shared drug pathways.Pharmacogenomics11(3) , 327–340 (2010).
  • Chomczynski P : A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples.Biotechniques15(3) , 532–534, 536–537 (1993).
  • Thomas PD , KejariwalA, CampbellMJ et al.: PANTHER: a browsable database of gene products organized by biological function, using curated protein family and subfamily classification.Nucleic Acid Res.31(1) , 334–341 (2003).
  • Irizarry RA , HobbsB, CollinF et al.: Exploration, normalization, and summaries of high density oligonucleotide array probe level data.Biostatistics4(2) , 249–264 (2003).
  • de Brouwer AP , van Bokhoven H, Kremer H: Comparison of 12 reference genes for normalization of gene expression levels in Epstein-Barr virus-transformed lymphoblastoid cell lines and fibroblasts. Mol. Diagn. Ther.10(3) , 197–204 (2006).
  • Wang Y , BarbacioruC, HylandF et al.: Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays.BMC Genomics7 , 59 (2006).
  • Teslovich TM , MusunuruK, SmithAV et al.: Biological, clinical and population relevance of 95 loci for blood lipids.Nature466(7307) , 707–713 (2010).
  • Rollins B , MartinMV, MorganL, VawterMP: Analysis of whole genome biomarker expression in blood and brain.Am. J. Med. Genet. B Neuropsychiatr. Genet.153B(4) , 919–936 (2010).
  • Duan S , HuangRS, ZhangW et al.: Expression and alternative splicing of folate pathway genes in HapMap lymphoblastoid cell lines.Pharmacogenomics10(4) , 549–563 (2009).
  • Le Fevre AC , BoitierE, MarchandeauJP, SarasinA, ThybaudV: Characterization of DNA reactive and non-DNA reactive anticancer drugs by gene expression profiling.Mutat Res.619(1–2) , 16–29 (2007).
  • Barkan T , GurwitzD, LevyG, WeizmanA, RehaviM: Biochemical and pharmacological characterization of the serotonin transporter in human peripheral blood lymphocytes.Eur. Neuropsychopharmacol.14(3) , 237–243 (2004).
  • Zhang W , HuangRS, DuanS, DolanME: Gene set enrichment analyses revealed differences in gene expression patterns between males and females.In Silico Biol.9(3) , 55–63 (2009).
  • Sakurai K , MigitaO, ToruM, ArinamiT: An association between a missense polymorphism in the close homologue of L1 (CHL1, CALL) gene and schizophrenia.Mol. Psychiatry7(4) , 412–415 (2002).
  • Chen QY , ChenQ, FengGY et al.: Case-control association study of the close homologue of L1 (CHL1) gene and schizophrenia in the Chinese population.Schizophr. Res.73(2–3) , 269–274 (2005).
  • Frints SG , MarynenP, HartmannD et al.: CALL interrupted in a patient with non-specific mental retardation: gene dosage dependent alteration of murine brain development and behavior.Hum. Mol. Genet.12(13) , 1463–1474 (2003).
  • Maness PF , SchachnerM: Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration.Nat. Neurosci.1 , 19–26 (2007).
  • Montag-Sallaz M , BaarkeA, MontagD. Aberrant neuronal connectivity in CHL1-deficient mice is associated with altered information processing-related immediate early gene expression. J. Neurobiol.57(1) , 67–80 (2003).
  • Montag-Sallaz M , SchachnerM, MontagD: Misguided axonal projections, neural cell adhesion molecule 180 mRNA upregulation, and altered behavior in mice deficient for the close homolog of L1.Mol Cell Biol.22(22) , 7967–7981 (2002).
  • Morellini F , LepsveridzeE, KählerB, DityatevA, SchachnerM: Reduced reactivity to novelty, impaired social behavior, and enhanced basal synaptic excitatory activity in perforant path projections to the dentate gyrus in young adult mice deficient in the neural cell adhesion molecule CHL1.Mol. Cell. Neurosci.34(2) , 121–136 (2007).
  • Desarnaud F , JakovcevskiM, MorelliniF, SchachnerM: Stress downregulates hippocampal expression of the adhesion molecules NCAM and CHL1 in mice by mechanisms independent of DNA methylation of their promoters.Cell Adh. Migr.2(1) , 38–44 (2008).
  • Demyanenko GP , SiesserPF, WrightAG et al.: L1 and CHL1 cooperate in thalamocortical axon targeting.Cereb. Cortex21(2) , 401–412 (2011).
  • Demyanenko GP , HalberstadtAI, RaoRS, ManessPF: CHL1 cooperates with PAK1–3 to regulate morphological differentiation of embryonic cortical neurons.Neuroscience165(1) , 107–115 (2010).
  • Huang X , ZhuLL, ZhaoT et al.: CHL1 negatively regulates the proliferation and neuronal differentiation of neural progenitor cells through activation of the ERK1/2 MAPK pathway.Mol. Cell Neurosci.46(1) , 296–307 (2011).
  • Laifenfeld D , KarryR, KleinE, Ben-ShacharD: Alterations in cell adhesion molecule L1 and functionally related genes in major depression: a postmortem study.Biol. Psychiatry57(7) , 716–725 (2005).
  • Verhaagen J , OestreicherAB, GrilloM et al.: Neuroplasticity in the olfactory system: differential effects of central and peripheral lesions of the primary olfactory pathway on the expression of B-50/GAP43 and the olfactory marker protein.J. Neurosci. Res.26(1) , 31–44 (1990).
  • Leu B , KochE, SchmidtJT: GAP43 phosphorylation, is critical for growth and branching, of retinotectal arbors in zebrafish.Dev. Neurobiol.70(13) , 897–911 (2010).
  • Zaccaria KJ , LagaceDC, EischAJ, McCaslandJS: Resistance to change and vulnerability to stress: autistic-like features of GAP43 deficient mice.Genes Brain Behav.9(8) , 985–996 (2010).
  • Valerio A , FerrarioM, MartinezFO et al.: Gene expression profile activated by the chemokine CCL5/RANTES in human neuronal cells.J. Neurosci Res.78(3) , 371–382 (2004).
  • Park MH , LeeYK, LeeYH et al.: Chemokines released from astrocytes promote chemokine receptor 5-mediated neuronal cell differentiation.Exp. Cell Res.315(16) , 2715–2726 (2009).
  • Cao L , JiaoX, ZuzgaDS, LiuY, FongDM, YoungD, DuringMJ: VEGF links hippocampal activity with neurogenesis, learning and memory.Nat. Genet.36(8) , 827–835 (2004).
  • Krum JM , ManiN, RosensteinJM: Roles of the endogenous VEGF receptors flt-1 and flk-1 in astroglial and vascular remodeling after brain injury.Exp. Neurol.212(1) , 108–117 (2008).
  • Gross I , ArmantO, BenosmanS et al.: Sprouty2 inhibits BDNF-induced signaling and modulates neuronal differentiation and survival.Cell Death Differ.14(10) , 1802–1812 (2007).
  • Ongür D , PohlmanJ, DowAL et al.: Electroconvulsive seizures stimulate glial proliferation and reduce expression of Sprouty2 within the prefrontal cortex of rats.Biol. Psychiatry62(5) , 505–512 (2007).
  • Jahn O , TenzerS, WernerHB. Myelin proteomics: molecular anatomy of an insulating sheath. Mol. Neurobiol.40(1) , 55–72 (2009).
  • Verma R , HolmansP, KnowlesJA et al.: Linkage disequilibrium mapping of a chromosome 15q25–26 major depression linkage region and sequencing of NTRK3.Biol. Psychiatry63(12) , 1185–1189 (2008).
  • Djurovic S , Le Hellard S, Kähler AK et al.: Association of MCTP2 gene variants with schizophrenia in three independent samples of Scandinavian origin (SCOPE). Psychiatry Res.168(3) , 256–258 (2009).
  • Craddock N , JonesL, JonesIR et al.: Strong genetic evidence for a selective influence of GABAA receptors on a component of the bipolar disorder phenotype.Mol Psychiatry.15(2) , 146–153 (2010).
  • Sequeira A , MamdaniF, ErnstC et al.: Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression.PLoS One.4(8) , e6585 (2009).
  • Aston C , JiangL, SokolovBP: Transcriptional profiling reveals evidence for signaling and oligodendroglial abnormalities in the temporal cortex from patients with major depressive disorder.Mol. Psychiatry10(3) , 309–322 (2005).
  • Amar S , ShaltielG, MannL: Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia.Int. J. Neuropsychopharmacol.11(2) , 197–205 (2008).
  • Cordin O , BanroquesJ, TannerNK, LinderP: The DEAD-box protein family of RNA helicases.Gene15(367) , 17–37 (2006).
  • Kuo PH , NealeMC, WalshD et al.: Genome-wide linkage scans for major depression in individuals with alcohol dependence.J. Psychiatr Res.44(9) , 616–619 (2010).
  • Castrén E , VõikarV, RantamäkiT: Role of neurotrophic factors in depression.Curr. Opin. Pharmacol.7(1) , 18–21 (2007).
  • Benusková L . Antidepressants and synaptic plasticity: a hypothesis. Med. Hypotheses.35(1) , 17–22 (1991).
  • Gorman JM , DochertyJP: A hypothesized role for dendritic remodeling in the etiology of mood and anxiety disorders.J. Neuropsychiatry Clin. Neurosci.22(3) , 256–264 (2010).
  • Bjartmar L , AlkhoriL, RuudJ et al.: Long-term treatment with antidepressants, but not environmental stimulation, induces expression of NP2 mRNA in hippocampus and medial habenula.Brain Res.1328 , 25–33 (2010).
  • Chen F , MadsenTM, WegenerG, NyengaardJR: Imipramine treatment increases the number of hippocampal synapses and neurons in a genetic animal model of depression.Hippocampus20(12) , 1376–1384 (2009).
  • Laifenfeld D , KleinE, Ben-ShacharD: Norepinephrine alters the expression of genes involved in neuronal sprouting and differentiation: relevance for major depression and antidepressant mechanisms.J. Neurochem.83(5) , 1054–1064 (2002).
  • Kovaru H , PavM, KovaruF, RabochJ, FiserovaA: Cell signalling in CNS and immune system in depression and during antidepressant treatment: focus on glial and natural killer cells.Neuro. Endocrinol. Lett.30(4) , 421–428 (2009).

▪ Websites

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.